Skip to content

Clinical trials

Phase 2 Arthritis trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Arthritis Phase: Phase 2 Country / region: United States Clear all

61 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20022
20042
20052
20065
20072
20082
20093
20103
20113
20122
20133
20143
20152
20163
20191
20201
20213
20227
20231
20241
20251
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed41
Terminated11
Withdrawn4
Unknown status2
Suspended1
Not yet recruiting1
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Aclaris Therapeutics, Inc.3
Eli Lilly and Company3
ZetrOZ, Inc.3
AbbVie2
BioCryst Pharmaceuticals2
Cara Therapeutics, Inc.2
Celgene2
National Center for Complementary and Integrative Health (NCCIH)2
National Center for Research Resources (NCRR)2
Novartis Pharmaceuticals2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Arthritis61
Arthritis, Rheumatoid21
Joint Diseases13
Osteoarthritis13
Connective Tissue Diseases8
Musculoskeletal Diseases8
Arthritis, Psoriatic6
Osteoarthritis, Knee6
Pain6
Rare Diseases6

Trials

Showing 1 to 25 of 61. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.